Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoqing Ma

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Diabetes, Obesity & Metabolism|January 15, 2024
Prusogliptin (DBPR108) monotherapy in treatment-naïve patients with type 2 diabetes: A randomized, double-blind, active and placebo-controlled, phase 3 studyWei Wang, Xiaohui Guo, Cheng Zhang, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 10, 2026
Associations of dietary diversity with constipation symptoms and gut microbiota features in individuals with functional constipationAmei Tang, Tian Tian, Wei Li, et al.
Journal of the American Heart Association|May 15, 2025
Potential Modulatory Roles of Gut Microbiota and Metabolites in the Associations of Macronutrient-to-Physical Activity Ratios With DyslipidemiaMenghan Wang, Guoqing Ma, Yunfeng Li, et al.
Current Medical Research and Opinion|September 5, 2024
Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 studyLinong Ji, Leili Gao, Zhifeng Cheng, et al.
Molecular Nutrition & Food Research|October 31, 2025
Conjugated Linoleic Acid Supplementation Suppresses the De Novo Lipogenesis in Adults With High Body Fat: A Double-Blind, Randomized, Placebo-Controlled TrialKaizhen Jia, Yongbo She, Yafang He, et al.
Molecular Nutrition & Food Research|June 16, 2025
Coarse Grain Preference, Gut Microbiota Features, in Relation to Hypertriglyceridemia in Constipation Patients: A Cross-Sectional StudyWei Li, Menghan Wang, Kun Xu, et al.
Molecular Nutrition & Food Research|September 15, 2023
Differential Gut Microbiota, Dietary Intakes in Constipation Patients with or without HypertensionJunqi Li, Guoqing Ma, Jiawen Xie, et al.
Journal of Diabetes Investigation|November 21, 2025
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 studyLeili Gao, Zhifeng Cheng, Guoqing Ma, et al.
Nature Communications|September 27, 2024
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 30, 2025
Habitual coarse grain intake, gut microbiota, and hyperuricemia in individuals with or at risk of metabolic syndrome: A post-hoc analysisJuan He, Yifei He, Junqi Li, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|January 15, 2024
Prusogliptin (DBPR108) monotherapy in treatment-naïve patients with type 2 diabetes: A randomized, double-blind, active and placebo-controlled, phase 3 studyWei Wang, Xiaohui Guo, Cheng Zhang, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 10, 2026
Associations of dietary diversity with constipation symptoms and gut microbiota features in individuals with functional constipationAmei Tang, Tian Tian, Wei Li, et al.
Journal of the American Heart Association|May 15, 2025
Potential Modulatory Roles of Gut Microbiota and Metabolites in the Associations of Macronutrient-to-Physical Activity Ratios With DyslipidemiaMenghan Wang, Guoqing Ma, Yunfeng Li, et al.
Current Medical Research and Opinion|September 5, 2024
Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 studyLinong Ji, Leili Gao, Zhifeng Cheng, et al.
Molecular Nutrition & Food Research|October 31, 2025
Conjugated Linoleic Acid Supplementation Suppresses the De Novo Lipogenesis in Adults With High Body Fat: A Double-Blind, Randomized, Placebo-Controlled TrialKaizhen Jia, Yongbo She, Yafang He, et al.
Molecular Nutrition & Food Research|June 16, 2025
Coarse Grain Preference, Gut Microbiota Features, in Relation to Hypertriglyceridemia in Constipation Patients: A Cross-Sectional StudyWei Li, Menghan Wang, Kun Xu, et al.
Molecular Nutrition & Food Research|September 15, 2023
Differential Gut Microbiota, Dietary Intakes in Constipation Patients with or without HypertensionJunqi Li, Guoqing Ma, Jiawen Xie, et al.
Journal of Diabetes Investigation|November 21, 2025
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 studyLeili Gao, Zhifeng Cheng, Guoqing Ma, et al.
Nature Communications|September 27, 2024
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 30, 2025
Habitual coarse grain intake, gut microbiota, and hyperuricemia in individuals with or at risk of metabolic syndrome: A post-hoc analysisJuan He, Yifei He, Junqi Li, et al.
Pageof 5